Relichem Pharma Profile
Key Indicators
- Authorised Capital ₹ 4.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.82 Cr
as on 12-12-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit 79.38%
(FY 2019)
- Ebitda 79.38%
(FY 2019)
- Net Worth -0.01%
(FY 2019)
- Total Assets -8.89%
(FY 2019)
About Relichem Pharma
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 1.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajendrakumar Holani, Rohitash Mandhana, and Suresh Mandhana serve as directors at the Company.
- CIN/LLPIN
U74120MH2012PTC235716
- Company No.
235716
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2012
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Relichem Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendrakumar Holani  | Additional Director | 10-Jan-2017 | Current |
| Rohitash Mandhana | Director | 13-Sep-2012 | Current |
| Suresh Mandhana | Additional Director | 27-Feb-2015 | Current |
Financial of Relichem Pharma.
Relichem Pharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 79.38% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Relichem Pharma?
In 2019, Relichem Pharma had a promoter holding of 85.24% and a public holding of 14.76%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chemserves Pharma Private LimitedActive 15 years 7 monthsRajendrakumar Holani, Rohitash Mandhana and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Relichem Pharma?
Unlock and access historical data on people associated with Relichem Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Relichem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relichem Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
